As of 2026-03-14, the Relative Valuation of THC Biomed Intl Ltd (THC.CN) is (0.20) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.02 CAD, the upside of THC Biomed Intl Ltd based on Relative Valuation is -1119.0%.
The range of the Relative Valuation is (0.22) - (0.21) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 3.6x - 4.7x | 4.2x |
| Forward P/E multiples | 4.9x - 5.0x | 5.0x |
| Fair Price | (0.22) - (0.21) | (0.20) |
| Upside | -1201.8% - -1143.6% | -1119.0% |
| Date | P/E |